Tag Archives: antiretroviral agents

April, 2016

  • 5 April

    Gilead’s HIV Therapy Descovy Receives FDA Approval

    FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 4, 2016– Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Descovy® (emtricitabine 200 mg/tenofovir alafenamide 25 mg, F/TAF), a fixed-dose combination for the treatment of HIV. Descovy is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in …